LivaNova PLC
NASDAQ:LIVN · NASDAQ Global Select
+$0.76 today
Vol 1.26M · Avg 0.79M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:LIVN · Revenue to Net Income
Key Ratios
Analysis
$1.4B of revenue converted into $107.1M of net income for the selected period. Gross margin is 67.6% and net margin is 7.5%, showing how much revenue survives after costs and taxes. EPS is $1.96, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.4B +10.7% | $1.3B +8.7% | $1.2B +12.9% | $1.0B -1.3% | $1.0B | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $448.2M +17.2% | $382.6M +0.1% | $382.3M +21.5% | $314.6M -4.5% | $329.4M | $725.6M | $804.0M | $882.4M |
| Gross Profit | $939.9M +7.9% | $870.9M +12.9% | $771.3M +9.1% | $707.2M +0.2% | $706.0M | $8.9B | $7.6B | $6.2B |
| Gross Margin | 67.7% -1.8pp | 69.5% +2.6pp | 66.9% -2.4pp | 69.2% +1.0pp | 68.2% | 9.8% | 28.9% | 38.3% |
| Research & Development | $185.8M +1.8% | $182.5M -5.8% | $193.8M +24.4% | $155.8M -15.1% | $183.4M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $548.8M +4.3% | $526.3M +1.6% | $518.1M +10.4% | $469.2M -0.6% | $471.9M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $740.5M -0.2% | $741.8M -11.7% | $839.7M +7.1% | $784.0M +10.9% | $706.8M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $42.0M -17.9% | $51.1M -16.0% | $60.9M +5.3% | $57.8M -15.0% | $68.0M | $374.2M | $1.2B | $631.8M |
| EBITDA | -$129.5M -163.9% | $202.5M +426.3% | $38.5M +24.5% | $30.9M +588.0% | -$6.3M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -9.3% -25.5pp | 16.2% +12.8pp | 3.3% +0.3pp | 3.0% +3.6pp | -0.6% | 5.6% | 46.3% | 42.0% |
| Operating Income | $199.4M +54.5% | $129.1M +288.4% | -$68.5M +10.8% | -$76.8M -9689.8% | -$784.0K | $12.3B | $14.0B | -$15.7B |
| Operating Margin | 14.4% +4.1pp | 10.3% +16.2pp | -5.9% +1.6pp | -7.5% -7.4pp | -0.1% | 16.6% | 24.1% | 22.0% |
| Interest Income | $19.0M -36.9% | $30.1M +36.6% | $22.0M +368.6% | $4.7M +979.8% | $435.0K | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $49.3M -21.9% | $63.1M +7.2% | $58.9M +22.0% | $48.3M -3.8% | $50.2M | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$420.2M -931.4% | -$40.7M -217.5% | -$12.8M -924.1% | $1.6M +101.3% | -$123.8M | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$220.8M -350.0% | $88.3M +208.6% | -$81.3M -8.2% | -$75.2M +39.7% | -$124.6M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -15.9% -23.0pp | 7.0% +14.1pp | -7.1% +0.3pp | -7.4% +4.7pp | -12.0% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $21.6M -13.8% | $25.1M +125.3% | -$98.9M -994.7% | $11.1M -1.3% | $11.2M | $1.3B | -$1.6B | $745.2M |
| Net Income | -$242.5M -483.5% | $63.2M +260.4% | $17.5M +120.3% | -$86.2M +36.5% | -$135.8M | $4.9B | $4.8B | $4.7B |
| Net Margin | -17.5% -22.5pp | 5.0% +3.5pp | 1.5% +10.0pp | -8.4% +4.7pp | -13.1% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$4 -480.3% | $1 +254.5% | $0 +120.5% | -$2 +39.9% | -$3 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$4 -483.6% | $1 +262.5% | $0 +119.9% | -$2 +39.9% | -$3 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $54.5M +0.5% | $54.2M +0.6% | $53.9M +0.7% | $53.5M +5.7% | $50.6M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $54.5M -0.1% | $54.6M +0.7% | $54.2M +1.3% | $53.5M +5.7% | $50.6M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Scholar Rock Holding Corporation
NASDAQ:SRRK
$5.66B
Cidara Therapeutics, Inc.
CDTX
$5.61B
Legend Biotech Corporation
NASDAQ:LEGN
$5.43B
IDEAYA Biosciences, Inc.
NASDAQ:IDYA
$2.96B
Heartflow, Inc. Common Stock
NASDAQ:HTFL
$2.86B
Disc Medicine, Inc.
NASDAQ:IRON
$2.70B
Prestige Consumer Healthcare Inc.
NYSE:PBH
$2.18B
Zai Lab Limited
NASDAQ:ZLAB
$2.08B
Surgery Partners, Inc.
NASDAQ:SGRY
$1.89B
Alphatec Holdings, Inc.
NASDAQ:ATEC
$1.29B
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does LIVN generate?
LivaNova PLC (LIVN) reported $1.39B of revenue in fiscal 2025.
Is LIVN profitable?
LivaNova PLC (LIVN) reported -$242,500,000.00 of net income, with a net margin of -17.5%.
Explore More
Continue the stock analysis
Jump to another research area for this company.